|

Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice

RECRUITINGSponsored by Yonsei University
Actively Recruiting
SponsorYonsei University
Started2025-09-22
Est. completion2027-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted

Summary

Valvular heart disease (VHD) is a growing public health concern globally, with increasing disease burden and rising interest in advanced treatment strategies such as transcatheter interventions. However, there remains a significant lack of real-world data regarding echocardiography practices, disease prevalence and progression, referral patterns, and treatment pathways. Addressing these gaps is critical for improving patient care and informing clinical decision-making. South Korea provides a unique opportunity to conduct a nationwide retrospective echocardiographic study due to its advanced healthcare infrastructure, high patient volume, and strong tradition in clinical research. The current study aims to evaluate the real-world burden and clinical journey of patients with moderate or severe valvular disease over a 10-year period, based on echocardiographic and electronic medical record (EMR) data collected from multiple tertiary centers across the country.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Period: 2010.1.1\~2020.12.31
* Age \> 18 years
* Moderate or severe native VHD (AS, AR, MR and TR)
* Perform echocardiography more than twice

Exclusion Criteria:

* Poor image of echocardiography
* Follow up loss

Conditions9

Aortic DiseasesAortic Valve InsufficiencyAortic Valve StenosisHeart DiseaseHeart Valve DiseasesMitral Valve InsufficiencyMitral Valve ProlapseRheumatic Heart DiseaseTricuspid Valve Insufficiency

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.